Cargando…
Uncommon presentation of morphea related to interferon beta in a patient with concomitant multiple sclerosis and chronic hepatitis C: A case report
Recombinant interferon beta‐1b is one of the treatment options of multiple sclerosis (MS). Insertional biologics that are used in the treatment of MS may lead to skin adverse effects, for example, morphea.
Autores principales: | Gupta, Mrinal, Yamauchi, Paul S., Bagot, Martine, Szepietowski, Jacek, Bhatia, Shibani, Lotti, Torello, Goldust, Mohamad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495805/ https://www.ncbi.nlm.nih.gov/pubmed/32983469 http://dx.doi.org/10.1002/ccr3.2971 |
Ejemplares similares
-
Interferon beta-1a–induced morphea
por: Bezalel, Spencer A., et al.
Publicado: (2014) -
Failure of response to combination therapy of adalimumab and infliximab in a recalcitrant patient of severe psoriasis and major thalassemia: A case report
por: Goldust, Mohamad, et al.
Publicado: (2020) -
Morphea Profunda Masquerading as Prurigo Nodularis: An Uncommon Presentation
por: Rao, Angoori G., et al.
Publicado: (2022) -
En coup de sabre morphea: an uncommon condition in Africa
por: Makhakhe, Lehlohonolo, et al.
Publicado: (2022) -
Concomitant appearance of morphea and vitiligo in a patient with autoimmune thyroiditis
por: Yorulmaz, Ahu, et al.
Publicado: (2016)